Diabetes Mellitus, Type 2

• Novartis Investigative Site — Beijing, Beijing Municipality, China
• Novartis Investigative Site — Shijiazhuang, Hebei, China
• Novartis Investigative Site — Wuhan, Hubei, China
• Novartis Investigative Site — Changsha, Hunan, China

• For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. — Helsinki, Finland

• San Diego VMC — San Diego, California, United States

• Neptune City, New Jersey, United States

• Rashid Centre for Diabetes and Research — Ajman, United Arab Emirates

Not specified

• Diabetes Unit E. Wolfson Hospital — Holon, Tel Aviv, Israel

• Profil Institute for Clinical Research, Inc. — Chula Vista, California, United States
• SeaView Research, Inc — Miami, Florida, United States
• Translational Research Institute-Florida Hospital — Orlando, Florida, United States

• Laboratório de Bioquímica da Nutrição, Núcleo de Nutrição e Medicina Tropical, Universidade de Brasília — Brasília, Federal District, Brazil

• 1218.18.54001 Boehringer Ingelheim Investigational Site — Capital Federal, Argentina
• 1218.18.54002 Boehringer Ingelheim Investigational Site — Capital Federal, Argentina
• 1218.18.54004 Boehringer Ingelheim Investigational Site — Capital Federal, Argentina
• 1218.18.54005 Boehringer Ingelheim Investigational Site — Capital Federal, Argentina